期刊文献+

Necrostatin-1对阿尔茨海默病细胞模型的保护作用 被引量:3

Neuroprotective effects of necrostatin-1 on the cellular model of Alzheimer's disease
下载PDF
导出
摘要 目的:研究程序性坏死在阿尔茨海默病(AD)中的作用及Necrostatin-1(Nec-1)对其保护机制。方法:采用25μmol/L Aβ_(25-35)作用于原代培养的小鼠皮层神经元36 h,复制AD细胞模型,分别加入不同浓度的Nec-1进行干预,采用MTT法评价细胞的存活率,试剂盒检测LDH的漏出量,用活细胞碘化丙啶(PI)染色观察细胞坏死的情况,用Western Blot检测细胞的RIPK1、RIPK3和磷酸化MLKL蛋白的表达情况。结果:与对照组相比,模型组细胞存活率明显降低(P<0.05),上清中LDH含量明显升高,PI阳性细胞数量明显增多,有聚集成团现象,细胞RIPK1、RIPK3和MLKL蛋白表达量水平均明显升高(P<0.01)。Nec-1处理后对Aβ细胞毒性作用有明显的减轻,RIPK1、RIPK3和磷酸化MLKL蛋白表达量较模型组明显下降(P<0.05,P<0.01)。结论:Aβ_(25-35)模拟的AD细胞模型中发生了程序性细胞坏死,Nec-1可能通过对抗程序性细胞坏死发挥神经保护作用。 Objective: To investigate the role of programmed necrosis and the protective mechanism of necrostatin-1( Nec-1) in Alzheimer's disease( AD). Methods: AD cellular model was established,Aβ(25-35) was used to treat the primary cultured cortical neurons from fetal mice at the final concentration of 25 μmol/L for 36 hours. Cells were treated with different concentrations of Nec-1. MTT assay was used to observe the cell vitality; the kit was adapted to measure LDH leakage quantity; living cells propidium iodide( PI) staining was used to observe the cell necrosis. Western Blot was used to detect the expressions of RIPK1,RIPK3 and phosphorylated MLKL( p MLKL) protein. Results: The cell vitality was decreased,the LDH content in supernatant was significantly increased( P〈0. 05) and the numbers of PI positive cells were obviously increased and the expressions of RIPK1,RIPK3 and p MLKL were significantly higher in AD model compared with the control group( P〈0. 01). Moreover,the neurons in AD model often gather to form a glomeration. The toxicity effectives of Aβ(25-35) was significantly reduced after the Nec-1 treatment,the expressions of RIPK1,RIPK3 and p MLKL were significantly lower than that in the model group( P〈0. 05,P〈0. 01). Conclusion: Necroptosis occurred in AD cell model induced by Aβ(25-35). Nec-1 plays a neuroprotective role in the pathological processby fightingagainst programmed cell necrosis.
作者 杨吉平 费琳 赵朝华 樊文科 成娟娟 苟兴春 Yang Jiping;Fei Lin;Zhao Zhaohua;Fan Wenke;Cheng Juanjuan;Gou Xingchun(Institute of Basic Medical Sciences, and Shaanxi Key Laboratory of Brain Disorders, Xi'an Medical University , Xi'an 710021;Departments of Psychiatry and Psychology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China)
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2018年第3期399-403,共5页 Chinese Journal of Neuroanatomy
基金 国家自然科学基金(81471415) 陕西省自然科学基础研究计划资助项目(2017JM8061) 西安医学院国家基金培育项目(2017GJFY22)
关键词 阿尔茨海默病 程序性坏死 Necrostatin-1 细胞培养 Alzheimer's disease necroptosis Neerostatin-1 cell culture
  • 相关文献

参考文献1

二级参考文献19

  • 1Cencioni MT, Santini S, Ruocco G, Borsellino G, De Bardi M, Grasso MG, Ruggieri S, Gasperini C, Centonze D, Barila D, Battistini L, Volpe E (2015) FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients. Cell Death Dis 6:e 1741.
  • 2Chanvillard C, Jacolik RF, Infante-Duarte C, Nayak RC (2013) The role of natural killer cells in multiple sclerosis and their therapeutic implications. Front Immunol 4:63.
  • 3Elkins J, Sheridan J, Amaravadi L, Riester K, Selmaj K, Bielekova B, Parr E, Giovannoni G (2015) CD56(bright) natural killer cells and response to daclizumab HYP in relaps- ing-remitting MS. Neurol Neuroimmunol Neuroinflamm 2:e65.
  • 4Fernandez-Paredes L, de Diego RP, de Andres C, Sanchez-Ramon S (2016) Close en- counters of the first kind: innate sensors and multiple sclerosis. Mol Neurobiol doi:10.1007/s12035-015-9665-5.
  • 5Hagman S, Kolasa M, Basnyat P, Helminen M, Kahonen M, Dastidar P, Lehtimaki T, Elovaara I (2015) Analysis of apoptosis-related genes in patients with clinically isolat- ed syndrome and their association with conversion to multiple sclerosis. J Neuroim muno1280:43-48.
  • 6Haider L, Fischer MT, Frischer JM, Bauer J, Hoeftberger R, Botond G, Bsterbauer H, Binder CJ, Witztum JL, Lassmanu H (2011) Oxidative damage in multiple sclerosis lesions. Brain 134:1914-1924.
  • 7Hoglund RA, Holmoy T, Harbo HF, Maghazachi AA (2013) A one year follow-up study of natural killer and dendritic cells activities in multiple sclerosis patients receiving glatiramer acetate (GA). PLoS One 8:e62237.
  • 8Johnson TA, Evans BL, Durafourt BA, Blain M, Lapierre Y, Bar-Or A, Antel JP (2011) Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patients. J Immunol 187:570-579.
  • 9Macchi B, Matteucci C, Nocentini U, Caltagirone C, Mastino A (1999) Impaired apopto- sis in mitogen-stimulated lymphocytes of patients with multiple sclerosis. Neurore- port 10:399-402.
  • 10Macchi B, Matteucci C, Nocentini U, Tacconi S, Pagnini V, Mastino A, Caltagirone C (2001) Defective Fas ligand productions in lymphocytes from MS patients. Neurore- port 12:4113-4116.

共引文献2

同被引文献16

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部